Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...
The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer ...
The therapy uses Tumor Treating Fields, or electric fields, to kill cancer cells while sparing most nearby healthy cells, ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Dec 2 (Reuters) - Novocure (NVCR.O), opens new tab said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy ...
Theriva Biologics, Inc. recently disclosed the outcomes of a Type D meeting with the U.S. Food and Drug Administration (FDA), outlining details regarding the design of a Phase 3 clinical study ...
Researchers have identified genetic variants linked to pancreatic cancer in Brazilian patients, offering new insights for ...